Stockreport

U.S. FDA declines to approve Merck-Daiichi's ‘guided missile' cancer drug [CNBC]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF The FDA cited findings from an inspection of a third-party manufacturing facility in its so-called complete response letter, the companies said late on Wednesday. The [Read more]